Stomach cancer surgery after chemo for limited spread
Part of Cancer, Digestive system clinical trials.
This trial tests if surgery to remove the stomach and some tumors, after a few months of chemo, helps people whose stomach cancer has spread to only a few nearby spots (like the lining of the belly, liver, or lymph nodes) live longer compared to chemo alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- Your stomach cancer has spread to only a few places, such as the lining of the belly, liver (spots no bigger than 5 cm), or certain lymph nodes near the spine.
- You have completed at least 4 cycles of standard first-line chemotherapy without the cancer growing.
- Your doctor has checked with a tiny camera in your belly (laparoscopy) and says surgery to remove all visible cancer is possible.
- You are healthy enough for surgery and have good kidney, liver, and blood cell counts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests combining chemotherapy, immunotherapy, and radiation before surgery for stomach or gastroesophageal junction cancer that has spread to a limited number of sites. The goal is to see if this approach can improve outcomes by shrinking tumors before they are removed.
This trial tests a minimally invasive surgery for stomach cancer that has spread to lymph nodes near the main blood vessels (para-aortic area). The surgery is done after a combination of chemotherapy and immunotherapy to shrink the tumor. It aims to see if this approach is safe and effective.
This Phase 3 trial compares two approaches for metastatic (spread to distant organs) stomach cancer: palliative surgery after a prior “translational” treatment versus ongoing maintenance chemotherapy. It aims to see which approach leads to better overall outcomes and symptom control.
This trial tests a combination of an immunotherapy drug (PD-1 antibody) plus chemotherapy or targeted therapy, followed by surgery, for people with stomach cancer that has spread to a limited number of other sites. The goal is to see if this approach can help shrink the cancer enough to make surgery more effective.
This study tests whether a thorough surgery to remove stomach cancer in the abdomen, followed by chemotherapy given through the belly and by vein, can improve outcomes. It’s for people newly diagnosed with stomach cancer that has limited spread to the belly lining.
This trial compares two approaches for stomach cancer that has spread to the abdominal lining after initial treatment (conversion therapy). One group receives surgery to remove the cancer, while the other does not. The goal is to see if surgery improves outcomes in patients who responded well to the initial treatment.
Hear when a new Metastatic Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.